Efficacy, Safety, and Pharmacokinetics/Pharmacodynamic Study of L-Dopa/Carbidopa To Treat Parkinson's Disease
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
Determine if a novel levodopa/carbidopa formulation results in a better clinical response on
Parkinson's Disease patients compared to the reference formulation of levodopa/carbidopa in
terms of motor complications, onset of action and response duration.
Phase:
Phase 2
Details
Lead Sponsor:
Osmotica Pharmaceutical US LLC
Treatments:
Carbidopa Carbidopa, levodopa drug combination Levodopa